CR9481A - Mimeticuerpos de peptido similar a glucagon-1 humanos, composiciones, metodos y usos - Google Patents

Mimeticuerpos de peptido similar a glucagon-1 humanos, composiciones, metodos y usos

Info

Publication number
CR9481A
CR9481A CR9481A CR9481A CR9481A CR 9481 A CR9481 A CR 9481A CR 9481 A CR9481 A CR 9481A CR 9481 A CR9481 A CR 9481A CR 9481 A CR9481 A CR 9481A
Authority
CR
Costa Rica
Prior art keywords
methods
compositions
mimeticbodies
glucagon
humans
Prior art date
Application number
CR9481A
Other languages
English (en)
Spanish (es)
Inventor
T O'neil Karyn
Picha Kristen
Original Assignee
Centocor Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centocor Inc filed Critical Centocor Inc
Publication of CR9481A publication Critical patent/CR9481A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/605—Glucagons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2318/00—Antibody mimetics or scaffolds
    • C07K2318/10—Immunoglobulin or domain(s) thereof as scaffolds for inserted non-Ig peptide sequences, e.g. for vaccination purposes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Cardiology (AREA)
  • Toxicology (AREA)
  • Hematology (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Immunology (AREA)
  • Obesity (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CR9481A 2005-03-28 2007-10-29 Mimeticuerpos de peptido similar a glucagon-1 humanos, composiciones, metodos y usos CR9481A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2005097175 2005-03-28

Publications (1)

Publication Number Publication Date
CR9481A true CR9481A (es) 2009-01-14

Family

ID=38256744

Family Applications (1)

Application Number Title Priority Date Filing Date
CR9481A CR9481A (es) 2005-03-28 2007-10-29 Mimeticuerpos de peptido similar a glucagon-1 humanos, composiciones, metodos y usos

Country Status (12)

Country Link
EP (1) EP1871811A4 (pt)
JP (1) JP2008546373A (pt)
KR (1) KR20080005378A (pt)
CN (1) CN101389346A (pt)
AU (1) AU2005339797A1 (pt)
BR (1) BRPI0520168A2 (pt)
CA (1) CA2603359A1 (pt)
CR (1) CR9481A (pt)
IL (1) IL186307A0 (pt)
MX (1) MX2007011975A (pt)
NO (1) NO20075272L (pt)
WO (1) WO2007081302A2 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200843794A (en) 2006-12-21 2008-11-16 Centocor Inc Use of long-acting GLP-1 receptor agonists to improve insulin sensitivity and lipid profiles
CN111574583B (zh) * 2020-04-10 2021-06-25 上海海路生物技术有限公司 蛋白复性试剂及其应用
CN120741086A (zh) * 2024-07-26 2025-10-03 荣耀终端股份有限公司 模拟人体组织液及其制备方法和应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6656728B1 (en) * 1999-02-08 2003-12-02 Chiron Corporation Fibroblast growth factor receptor-immunoglobulin fusion
UA93662C2 (uk) * 2000-12-07 2011-03-10 Эли Лилли Энд Компани Гетерологічний пептидильований глюкагон-подібний білок та його застосування для виготовлення лікарського засобу для лікування пацієнтів, що страждають на ожиріння або інсулінонезалежний цукровий діабет
WO2004002424A2 (en) * 2002-06-28 2004-01-08 Centocor, Inc. Mammalian epo mimetic ch1 deleted mimetibodies, compositions, methods and uses
AU2003280130B2 (en) * 2002-06-28 2009-06-11 Centocor, Inc. Mammalian CH1 deleted mimetibodies, compositions, methods and uses
WO2005005604A2 (en) * 2003-06-30 2005-01-20 Centocor, Inc. Engineered anti-target immunoglobulin derived proteins, compositions, methods and uses
KR20070004078A (ko) * 2004-03-31 2007-01-05 센토코 인코포레이티드 인간 ｇｌｐ-1 모방체, 조성물, 방법 및 용도

Also Published As

Publication number Publication date
CA2603359A1 (en) 2007-07-19
WO2007081302A3 (en) 2008-11-13
JP2008546373A (ja) 2008-12-25
KR20080005378A (ko) 2008-01-11
CN101389346A (zh) 2009-03-18
EP1871811A4 (en) 2009-07-22
NO20075272L (no) 2007-12-28
BRPI0520168A2 (pt) 2009-04-22
EP1871811A2 (en) 2008-01-02
WO2007081302A2 (en) 2007-07-19
AU2005339797A1 (en) 2007-07-19
IL186307A0 (en) 2008-01-20
MX2007011975A (es) 2008-03-14

Similar Documents

Publication Publication Date Title
UY30494A1 (es) Mimeticuerpos de glp-1 humanos, composiciones, métodos y usos
AR049014A1 (es) Mimeticuerpos de glp-1 humanos , composiciones y usos
CR8320A (es) Mimeticuerpos humanos centrales de la region de bisagra, mimeticos de la eritropoyetina, composiciones, metodos y usos
CR9606A (es) Anticuerpos anti-proteina quinoatrayente de monocitos-1, composiciones, metodos y usos
NI200700158A (es) Agonistas glp-1, composiciones, métodos y usos
NI201000056A (es) Anticuerpos anti-amiloides, composiciones, métodos y usos.
HN2006016512A (es) Anticuerpos anti-il-6, composiciones, metodos y usos
CR9443A (es) Vacuna de toxoide de c. perfringens alfa
CR9514A (es) Antagonistas de npy, preparacion y usos
UY29128A1 (es) Proteinas derivadas de inmunoglobulina específica de il-23p40, composiciones, epitopes, métodos y usos
UY30820A1 (es) Uso de agonistas del receptor de glp-1 de accion prolongada para mejorar la sensibilidad a la insulina y los perfiles lipidicos
PE20220960A1 (es) Proteinas de variantes de secuencias de aminoacidos de cry1da1 activas para lepidopteros
HN2003000063A (es) Derivados de nicotinamida y una sal de tiotropio en combinacion para el tratamiento de enfermedades.
BRPI0418365A (pt) ativação por planta de toxina de inseto
CR9481A (es) Mimeticuerpos de peptido similar a glucagon-1 humanos, composiciones, metodos y usos
GT200500094A (es) Formulaciones liquidas administrables pro via dermica para combatir artropodos parasitos en animales
GT200500070A (es) Compuestos de sulfonamidas para el tratamiento de trastornos neurodegenerativos
UY27973A1 (es) Debencenoxazepinas
CL2007003811A1 (es) Inhibidores de proteasa no naturales del tipo de kunitz que tienen entre 56-60 aminoacidos; acido nucleico que codifica un inhibidor de proteasa no natural; uso de dicho inhibidor para tratamiento de hemorragias.
AR030133A1 (es) Anticuerpos anti-tnf, composiciones, metodos y usos
UY29552A1 (es) Anticuerpos anti-mcp-1, composiciones, métodos y usos
ES2337005R (es) Compuestos de pirazolina azepan o azocansustituidos, su preparacion y su uso como medicamentos.
DOP2003000696A (es) Debencenoxazepinas
GT200600212A (es) Anticuerpos anti-mcp-1, composiciones, metodos y usos
AR030135A1 (es) Anticuerpos de integrina anti-dual, composiciones, metodos y usos

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)